The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 86

More JCP Articles

JCP
Commentary

March 31, 2020

In this commentary, Dr Corruble gives an account from the front lines of treating psychiatric patients during the COVID-19 outbreak in Paris, France.
JCP
Original Research

March 31, 2020

Psychiatric patients are susceptible to cardiovascular disease (CVD), but this risk is poorly understood. This study compared CVD risk in psychiatric patients taking weight gain-inducing drugs with that in…
, , , et al
JCP
Commentary

March 31, 2020

In this commentary, the authors describe the hospital environment and the protective measures being taken during the COVID-19 pandemic in a hospital in Tuscany, Italy.
, ,
JCP
Editorial

March 31, 2020

The COVID-19 pandemic has demonstrated how connected we are—both in kinship and in a devastating manner. In this editorial, JCP’s Editor in Chief comments on the emerging challenges faced…
JCP
Review Article

March 31, 2020

In this CME journal article, the authors describe a case of new-onset psychosis in a middle-aged woman, review red-flags for a neurodegenerative diagnosis rather than a primary psychotic disorder,…
, , , et al
JCP
Letter to the Editor

March 24, 2020

In this letter to the editor, Dr Modrego comments on a recent study by Cheng et al that focused on mortality predictors in Taiwanese patients with dementia.
JCP
Letter to the Editor

March 24, 2020

Cheng et al reply to the letter “Behavioral Symptoms Improve Prediction Models of Mortality in Patients With Dementia” by Modrego.
, , , et al
JCP
Meta-Analysis

March 24, 2020

For ADHD patients who responded to medication treatments, does discontinuing those medications affect quality of life more adversely than continuing them? This study compares the effects of continuing versus…
, , , et al
JCP
Original Research

March 24, 2020

How soon is too soon to look for metabolic syndrome in your patients with schizophrenia? This randomized open-label trial investigates 7 risk factors of 5 atypical and 2 typical…
, , , et al
JCP
Clinical and Practical Psychopharmacology

March 24, 2020

The fragility index is the smallest number of subjects whose status needs to change for a significant finding to lose its significance. Read this article to learn about the…
JCP
Educational Activity

March 24, 2020

What can you do to combat relapse in your patients with schizophrenia? Dr Lauriello discusses identifying and addressing a major contributor to relapse—nonadherence to antipsychotics.
JCP
Original Research

March 17, 2020

People with psychotic disorders are more likely to have alcohol use disorder than the general population, but how does that comorbidity affect the course of their psychosis? This analysis…
, , , et al

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe